A randomized, controlled trial on fenofibrate in primary biliary cholangitis patients with incomplete response to ursodeoxycholic acid

INTRODUCTION: About one-third of primary biliary cholangitis (PBC) patients do not exhibit complete response to ursodeoxycholic acid (UDCA). Some of these patients were reported to benefit from the combination therapy of fibrates and UDCA, but more clinical evidence is required. In this study, we co...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chunlei, Zheng, Kunyu, Chen, Yiran, He, Chengmei, Liu, Suying, Yang, Yunjiao, Li, Mengtao, Zeng, Xiaofeng, Wang, Li, Zhang, Fengchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340330/
https://www.ncbi.nlm.nih.gov/pubmed/35924008
http://dx.doi.org/10.1177/20406223221114198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340330/
https://www.ncbi.nlm.nih.gov/pubmed/35924008
http://dx.doi.org/10.1177/20406223221114198

Ejemplares similares